NHS England to fund Duodopa

News

Author: Parkinson's Life editorsPublished: 28 August 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The NHS in England has announced they will fund Duodopa – a life-changing drug for people with advanced Parkinson’s – after campaigners managed to garner the support of nearly a hundred MPs who signed a petition.

This means that should a specialist Parkinson’s clinician prescribe Duodopa, a patient will be able to receive it without delay. Duodopa can help to control the symptoms of advanced Parkinson’s when all other treatments have stopped working.

The petition signed by 98 MPs put pressure on NHS England to act urgently to address the situation.

Laura Cockram, policy and campaigns manager at Parkinson’s UK said: “I am elated that the NHS has finally arrived at this decision. We know this treatment has had transformative effects on many that have been treated with it and how vital it is that those who need Duodopa receive it without delay. This is an important day for Parkinson’s care.”

 

Go Back

Share this story

Comments


Related articles


compulsive behaviour

Special reports

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

READ MORE

Carers' Corner

New survey highlights challenges facing Parkinson’s carers

The EPDA launches a new multilingual survey for Parkinson’s carers

READ MORE
Angela Merkel

Global update

Angela Merkel sparks health concerns

The German chancellor was seen shaking at a recent event

READ MORE